← SynDRA
Mcc-950
SynDRA canonical compound SYN0054896 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | IL1B | NLRP3 |
| Mechanism of action | NOD like receptor inhibitor |
All known targets
Mechanisms of action (all sources)
- NLRP3 INHIBITOR
- NOD like receptor inhibitor
Cross-references
Synonyms
- CP-456773
- CRID3
- MCC950
- MCC950 (SODIUM)
- MCC 950
- CHEMBL3183703
- N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide
- DSSTox_RID_82252
- DSSTox_CID_27301
- DSSTox_GSID_47301
- SCHEMBL6521858
- GTPL8228
- DTXSID2047301
- MolPort-042-579-517
- EX-A1052
- BCP15729
- Tox21_300462
- BDBM50155926
- ZINC34025113
- AKOS030238802
- SB19010
- NCGC00254269-01
- NCGC00248064-01
- HY-12815
- CAS-210826-40-7
- 1-[4-(1-Hydroxy-1-methylethyl)-2-furylsulfonyl]-3-[(1,2,3,5,6,7-hexahydro-s-indacene)-4-yl]urea
- 6RS86E2BWQ
- CP-456,773
- DTXCID0027301
- RefChem:156084
- MFCD28900720
- UNII-6RS86E2BWQ
- 7YN
- orb1693248
- C20H24N2O5S
- CHEBI:231684
- GLXC-10741
- EBC-47045
Look up Mcc-950 in the interactive SynDRA portal →